Home > Boards > US Listed > Medical - Healthcare > Gilead Sciences, Inc. (GILD)

Gilead Gets an Upgrade With Street Mulling Remdesivir Profit

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
LionsTact Member Profile
 
Followed By 39
Posts 4,309
Boards Moderated 0
Alias Born 01/21/14
160x600 placeholder
Gilead Sciences to Release Fourth Quarter and Full Year 2020 Financial Results on Thursday, February 4, 2021 Business Wire - 1/21/2021 4:01:00 PM
Gilead Sciences Up Nearly 7%, Best Performer in the Nasdaq 100 So Far Today -- Data Talk Dow Jones News - 1/19/2021 12:07:00 PM
Francesco M. Marincola Joins Kite as Worldwide Head of Cell Therapy Research Business Wire - 1/19/2021 8:00:00 AM
Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chron... GlobeNewswire Inc. - 1/12/2021 8:00:00 AM
Gilead & Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic... Business Wire - 1/12/2021 8:00:00 AM
Gilead Lifts 2020 Guidance Driven By Remdesivir Demand; Shares Gain TipRanks - 1/11/2021 10:35:37 AM
Eli Lilly, Twitter, NIO: What to Watch When the Stock Market Opens Today Dow Jones News - 1/11/2021 8:12:00 AM
Gilead Raises Product Sales Guidance on Remdesivir Demand, Narrows Earnings Outlook for 2020 Dow Jones News - 1/11/2021 7:03:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/11/2021 6:05:36 AM
Gilead Sciences Announces Updated 2020 Guidance Business Wire - 1/11/2021 6:00:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 1/6/2021 5:26:18 PM
Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors Business Wire - 1/6/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 1:25:26 PM
Gilead Sciences or Biogen: Which Biotech Stock is a Better Pick for 2021? TipRanks - 1/3/2021 3:58:28 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/29/2020 3:09:53 PM
Gilead Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 Business Wire - 12/21/2020 4:01:00 PM
Galapagos Shares Drop 19% After Gilead Won't Seek FDA Approval for Jyseleca Dow Jones News - 12/16/2020 1:21:00 PM
Gilead, Galapagos Amend Arrangement on Jyseleca; Gilead Won't Pursue FDA Approval Dow Jones News - 12/16/2020 8:04:00 AM
Kite’s Tecartus™ (KTE-X19) Granted Conditional Marketing Authorization for the Treatment of Relapsed or Refractory Mantle... Business Wire - 12/16/2020 3:01:00 AM
Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca® (Filgotinib) Business Wire - 12/15/2020 4:15:00 PM
Gilead Advances Oncology Portfolio With New Data From Phase 3 ASCENT Trial of Trodelvy® in Metastatic Triple Negative Breast... Business Wire - 12/10/2020 4:48:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/10/2020 4:11:13 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/10/2020 4:08:10 PM
Gilead Sciences to Acquire MYR GmbH PR Newswire (US) - 12/10/2020 9:20:00 AM
Gilead to Pay $1.4 Billion for Hepatitis Drug Maker MYR GmbH of Germany Dow Jones News - 12/10/2020 8:29:00 AM
LionsTact   Wednesday, 05/27/20 09:23:19 PM
Re: LionsTact post# 3912
Post # of 4758 
Gilead Gets an Upgrade With Street Mulling Remdesivir Profit

May 26, 2020, Bloomberg

Quote:
Results from a late-stage Gilead-run study in moderate patients are expected this week and Van Buren said he was “now even more convinced” the data would be positive. Goldman Sachs analysts, who rate Gilead a sell, also expect the next trial to show a benefit and assumes Gilead will seek to break-even on remdesivir “at a minimum.”

The company has said it may spend $1 billion on remdesivir this year and plans to make the medicine “accessible and affordable” for governments and patients.



https://www.bloomberg.com/news/articles/2020-05-26/gilead-gets-an-upgrade-with-street-mulling-remdesivir-profit







Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences